Paper33301022
Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort.
MacInnis RJ and 20 others. J Natl Cancer Inst, 2021. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Comparing 5-Year and Lifetime Risks of Breast Cancer using the Prospective Family Study Cohort. Papers, record 33301022. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33301022
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Adult | |
| Cohort Studies | |
| Female | |
| Humans | |
| Prospective Studies | |
| ROC Curve | |
| Risk Assessment | |
| Risk Factors | |
| Young Adult |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| UM1 CA164920 | NCI NIH HHS | United States | U01CA164920 | PubMed and NIH | NIH RePORTER |
| UL1 TR001863 | NCATS NIH HHS | United States | UL1TR001863 | PubMed | NIH RePORTER |
| UL1 TR002538 | NCATS NIH HHS | United States | UL1TR002538 | PubMed and NIH | NIH RePORTER |
| R01 CA159868 | NCI NIH HHS | United States | R01CA159868 | PubMed and NIH | NIH RePORTER |
| U01 CA164920 | NCI NIH HHS | United States | U01CA164920 | PubMed and NIH | NIH RePORTER |
References20
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24753038 | Assessing the goodness of fit of personal risk models. | Stat Med | 2014 | https://conductscience.org/library/papers/24753038 | PubMed |
| 2 | 25956172 | Practical problems with clinical guidelines for breast cancer prevention based on remaining lifetime risk. | J Natl Cancer Inst | 2015 | https://conductscience.org/library/papers/25956172 | PubMed |
| 3 | 15217505 | The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. | Breast Cancer Res | 2004 | https://conductscience.org/library/papers/15217505 | PubMed |
| 4 | 15057881 | A breast cancer prediction model incorporating familial and personal risk factors. | Stat Med | 2004 | https://conductscience.org/library/papers/15057881 | PubMed |
| 5 | 16507150 | Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. | Breast Cancer Res | 2006 | https://conductscience.org/library/papers/16507150 | PubMed |
| 6 | 31114019 | A systematic review and quality assessment of individualised breast cancer risk prediction models. | Br J Cancer | 2019 | https://conductscience.org/library/papers/31114019 | PubMed |
| 7 | 26174520 | Cohort Profile: The Breast Cancer Prospective Family Study Cohort (ProF-SC). | Int J Epidemiol | 2016 | https://conductscience.org/library/papers/26174520 | PubMed |
| 8 | 30442736 | Breast Cancer Screening and Diagnosis, Version 3.2018, NCCN Clinical Practice Guidelines in Oncology. | J Natl Compr Canc Netw | 2018 | https://conductscience.org/library/papers/30442736 | PubMed |
| 9 | 29621362 | Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density. | JAMA Oncol | 2018 | https://conductscience.org/library/papers/29621362 | PubMed |
| 10 | 26501536 | Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. | JAMA | 2015 | https://conductscience.org/library/papers/26501536 | PubMed |
| 11 | 31853515 | Accuracy of Risk Estimates from the iPrevent Breast Cancer Risk Assessment and Management Tool. | JNCI Cancer Spectr | 2019 | https://conductscience.org/library/papers/31853515 | PubMed |
| 12 | 30799262 | 10-year performance of four models of breast cancer risk: a validation study. | Lancet Oncol | 2019 | https://conductscience.org/library/papers/30799262 | PubMed |
| 13 | 18932252 | The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. | Cancer | 2008 | https://conductscience.org/library/papers/18932252 | PubMed |
| 14 | 17392385 | American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. | CA Cancer J Clin | 2007 | https://conductscience.org/library/papers/17392385 | PubMed |
| 15 | 24346285 | BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface. | Br J Cancer | 2014 | https://conductscience.org/library/papers/24346285 | PubMed |
| 16 | 18704680 | BRCA1 and BRCA2 mutation carriers in the Breast Cancer Family Registry: an open resource for collaborative research. | Breast Cancer Res Treat | 2009 | https://conductscience.org/library/papers/18704680 | PubMed |
| 17 | 21750294 | Clinically relevant changes in family history of cancer over time. | JAMA | 2011 | https://conductscience.org/library/papers/21750294 | PubMed |
| 18 | 28944288 | The WISDOM Study: breaking the deadlock in the breast cancer screening debate. | NPJ Breast Cancer | 2017 | https://conductscience.org/library/papers/28944288 | PubMed |
| 19 | 15951960 | Predictors of participation in clinical and psychosocial follow-up of the kConFab breast cancer family cohort. | Fam Cancer | 2005 | https://conductscience.org/library/papers/15951960 | PubMed |
| 20 | 31584660 | Considerations When Using Breast Cancer Risk Models for Women with Negative BRCA1/BRCA2 Mutation Results. | J Natl Cancer Inst | 2020 | https://conductscience.org/library/papers/31584660 | PubMed |
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39666943 | Evaluating the performance of the Breast and Ovarian Analysis of Disease Incidence Algorithm model in predicting 10-year breast cancer risks in UK Biobank. | J Natl Cancer Inst | 2025 | https://conductscience.org/library/papers/39666943 | PubMed |
| 36622766 | Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort. | Cancer Epidemiol Biomarkers Prev | 2023 | https://conductscience.org/library/papers/36622766 | PubMed |
| 35876790 | Deep Learning vs Traditional Breast Cancer Risk Models to Support Risk-Based Mammography Screening. | J Natl Cancer Inst | 2022 | https://conductscience.org/library/papers/35876790 | PubMed |
| 35762939 | Breast cancer risk predictions by birth cohort and ethnicity in a population-based screening mammography program. | Br J Radiol | 2022 | https://conductscience.org/library/papers/35762939 | PubMed |
| 35406409 | Intention to Inform Relatives, Rates of Cascade Testing, and Preference for Patient-Mediated Communication in Families Concerned with Hereditary Breast and Ovarian Cancer and Lynch Syndrome: The Swiss CASCADE Cohort. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35406409 | PubMed |
| 35026019 | Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population. | J Natl Cancer Inst | 2022 | https://conductscience.org/library/papers/35026019 | PubMed |
| 34950851 | Recreational Physical Activity and Outcomes After Breast Cancer in Women at High Familial Risk. | JNCI Cancer Spectr | 2021 | https://conductscience.org/library/papers/34950851 | PubMed |
| 34680343 | Prospective Evaluation over 15 Years of Six Breast Cancer Risk Models. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34680343 | PubMed |
| 34575693 | Should Age-Dependent Absolute Risk Thresholds Be Used for Risk Stratification in Risk-Stratified Breast Cancer Screening? | J Pers Med | 2021 | https://conductscience.org/library/papers/34575693 | PubMed |
| 34531609 | Role of Routine Peritoneal Biopsies During Risk Reducing Salpingo-Oophorectomy (RRSO). | Geburtshilfe Frauenheilkd | 2021 | https://conductscience.org/library/papers/34531609 | PubMed |
| 34424438 | Understanding the Clinical Implications of Low Penetrant Genes and Breast Cancer Risk. | Curr Treat Options Oncol | 2021 | https://conductscience.org/library/papers/34424438 | PubMed |
| 33301010 | Identifying Preferred Breast Cancer Risk Predictors: A Holistic Perspective. | J Natl Cancer Inst | 2021 | https://conductscience.org/library/papers/33301010 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33301022
GET https://conductscience.org/api/papers/v1/33301022/authors?page=2